RESMED INC Annual Deferred Federal Income Tax Expense (Benefit) in USD from 2010 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Resmed Inc annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Resmed Inc annual Deferred Federal Income Tax Expense (Benefit) for 2024 was -$22.9M, a 5.5% decline from 2023.
- Resmed Inc annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$21.7M, a 72.2% decline from 2022.
- Resmed Inc annual Deferred Federal Income Tax Expense (Benefit) for 2022 was -$12.6M, a 44.7% increase from 2021.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)